Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06230432

Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
176 (estimated)
Sponsor
The First Affiliated Hospital of Nanchang University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to learn about the biomarkers and mechanisms of severe acute pancreatitis in 30 healthy controls, 30 patients of mild acute pancreatitis, 30 patients of moderately severe acute pancreatitis, and 86 patients of severe acute pancreatitis. The main question it aims to answer are: • The relationship between changes in gut microbiota and clinical prognosis (plasma inflammatory cytokines, incidence and duration of infection in various parts, mortality rate), and the screening and validation of biomarkers that can be used for early prediction of disease severity. • Analyze the relationship between changes in blood composition and clinical prognosis (plasma inflammatory cytokines, incidence and duration of infection in various parts, mortality rate), screen and verify biomarkers that can be used for early prediction of disease severity. Blood and fecal samples from the healthy control group and diagnosed patients will be collected.

Conditions

Timeline

Start date
2024-01-21
Primary completion
2025-03-09
Completion
2026-12-09
First posted
2024-01-30
Last updated
2024-01-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06230432. Inclusion in this directory is not an endorsement.